今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1713次   下载 1335 本文二维码信息
码上扫一扫!
分享到: 微信 更多
雷帕霉素对动脉粥样硬化小鼠斑块面积影响及机制探讨
王青龙1, 姜希娟2, 范英昌2, 庞晓丽3
1.天津中医药大学研究生院, 天津 300193;2.天津中医药大学中西医结合学院, 天津 300193;3.天津中医药大学护理学院, 天津 300193
摘要:
[目的]探讨雷帕霉素对ApoE基因敲除小鼠动脉粥样硬化斑块面积影响及机制。[方法]选取30只雄性ApoE基因敲除(ApoE-/-)小鼠为研究对象,将其随机分为模型组、雷帕霉素组、阳性药物(瑞伐他汀)组。高脂饮食12周后灌胃干预4周。处死后取主动脉斑块组织油红O和苏木精-伊红(HE)染色评估斑块脂质情况、斑块面积;采用酶联免疫吸附(ELISA)法测定外周血中促炎因子肿瘤坏死因子α(TNF-α)、γ干扰素(INF-γ)、白介素-6(IL-6)和转化因子β(TGF-β)、白介素-10(IL-10)表达情况。[结果]雷帕霉素组斑块面积明显小于模型组,差异有统计学意义(P<0.05);在炎症因子方面,雷帕霉素组能有效降低外周血TNF-α、INF-γ、IL-6表达,增加IL-10、TGF-β表达,差异有统计学意义(P<0.05)。[结论]雷帕霉素可通过增加抗炎因子含量、降低促炎因子含量来调控炎症反应,进而抑制斑块发展,降低血管狭窄程度。
关键词:  动脉粥样硬化  斑块  雷帕霉素
DOI:10.11656/j.issn.1672-1519.2018.08.16
分类号:R541.4
基金项目:国家自然科学基金资助项目(81603565,81573733)。
Researching the mechanism of rapamycin on area of plaque in atherosclerotic mice
WANG Qinglong1, JIANG Xijuan2, FAN Yingchang2, PANG Xiaoli3
1.Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;2.Combine Traditional Chinese and Western Medicine Institute of Tianjin University of Traditional Chinese Medixine, Tianjin 300193, China;3.Nursing School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Abstract:
[Objiective] To explore the mechanism and effect of rapamycin on plaque in ApoE-/- atherosclerotic mice.[Methods] ApoE-/- mice were divided into three groups:model group, rapamycin group and rosuvastatin group. There groups were fed with high cholesterol lipid feeding about 12 weeks, and then were treated with intragastric administration about 4 weeks. After killing at the end of experiment, the samples of aorta were collected for HE staining and Oil red staining to evaluate lipid nuclear and the area of plaque, using ELISA evaluating the content of TNF-α, INF-γ, IL-6, TGF-β, IL-10 in the serum of peripheral blood.[Results] The area of plaque was measured by image analysis after HE was found that rapamycin group was obviously reduced than model group (P<0.05). In terms of inflammatory factors, content of TNF-α, INF-γ, IL-6 in rapamycin group was marked decreased than model group (P<0.05). However, the level of IL-10,TGF-β was obviously increased comparing with model group (P<0.05).[Conclusion] Rapamycin can shrink the area of plaque and then reduce degree of vascular stenosis, which mechanism may be related to regulate the inflammation response.
Key words:  atherosclerosis  plaques  rapamycin
关注公众号二维码